Ultragenyx Announces Phase 3 Aspire Results In Angelman Syndrome
Ultragenyx Pharmaceutical Inc. NASDAQ:RARE
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
RARE - Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
RARE - Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome